329 related articles for article (PubMed ID: 19824828)
1. Preinvasive breast cancer.
Sgroi DC
Annu Rev Pathol; 2010; 5():193-221. PubMed ID: 19824828
[TBL] [Abstract][Full Text] [Related]
2. Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast.
Buerger H; Simon R; Schäfer KL; Diallo R; Littmann R; Poremba C; van Diest PJ; Dockhorn-Dworniczak B; Böcker W
Mol Pathol; 2000 Jun; 53(3):118-21. PubMed ID: 10897329
[TBL] [Abstract][Full Text] [Related]
3. Changes in tenascin-C isoform expression in invasive and preinvasive breast disease.
Adams M; Jones JL; Walker RA; Pringle JH; Bell SC
Cancer Res; 2002 Jun; 62(11):3289-97. PubMed ID: 12036947
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of preinvasive lesions adjacent to BRCA1/2-associated breast cancers.
Arun B; Vogel KJ; Lopez A; Hernandez M; Atchley D; Broglio KR; Amos CI; Meric-Bernstam F; Kuerer H; Hortobagyi GN; Albarracin CT
Cancer Prev Res (Phila); 2009 Feb; 2(2):122-7. PubMed ID: 19174581
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling of the tumor microenvironment during breast cancer progression.
Ma XJ; Dahiya S; Richardson E; Erlander M; Sgroi DC
Breast Cancer Res; 2009; 11(1):R7. PubMed ID: 19187537
[TBL] [Abstract][Full Text] [Related]
6. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
7. Impact of AdipoR1 expression on breast cancer development.
Pfeiler G; Hudelist G; Wülfing P; Mattsson B; Königsberg R; Kubista E; Singer CF
Gynecol Oncol; 2010 Apr; 117(1):134-8. PubMed ID: 20071013
[TBL] [Abstract][Full Text] [Related]
8. Preinvasive lesions of the bronchus.
Rivera MP
Clin Chest Med; 2011 Dec; 32(4):693-702. PubMed ID: 22054880
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of the tumor microenvironment in breast cancer.
Allinen M; Beroukhim R; Cai L; Brennan C; Lahti-Domenici J; Huang H; Porter D; Hu M; Chin L; Richardson A; Schnitt S; Sellers WR; Polyak K
Cancer Cell; 2004 Jul; 6(1):17-32. PubMed ID: 15261139
[TBL] [Abstract][Full Text] [Related]
10. Distinct epigenetic changes in the stromal cells of breast cancers.
Hu M; Yao J; Cai L; Bachman KE; van den Brûle F; Velculescu V; Polyak K
Nat Genet; 2005 Aug; 37(8):899-905. PubMed ID: 16007089
[TBL] [Abstract][Full Text] [Related]
11. PIK3CA mutations in in situ and invasive breast carcinomas.
Miron A; Varadi M; Carrasco D; Li H; Luongo L; Kim HJ; Park SY; Cho EY; Lewis G; Kehoe S; Iglehart JD; Dillon D; Allred DC; Macconaill L; Gelman R; Polyak K
Cancer Res; 2010 Jul; 70(14):5674-8. PubMed ID: 20551053
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of gelsolin expression in human breast ductal carcinoma in situ with and without invasion.
Asch HL; Winston JS; Edge SB; Stomper PC; Asch BB
Breast Cancer Res Treat; 1999 May; 55(2):179-88. PubMed ID: 10481945
[TBL] [Abstract][Full Text] [Related]
13. Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis.
Murphy DS; Hoare SF; Going JJ; Mallon EE; George WD; Kaye SB; Brown R; Black DM; Keith WN
J Natl Cancer Inst; 1995 Nov; 87(22):1694-704. PubMed ID: 7473818
[TBL] [Abstract][Full Text] [Related]
14. Epithelial cells captured from ductal carcinoma in situ reveal a gene expression signature associated with progression to invasive breast cancer.
Elias EV; de Castro NP; Pineda PH; Abuázar CS; Bueno de Toledo Osorio CA; Pinilla MG; da Silva SD; Camargo AA; Silva WA; E Ferreira EN; Brentani HP; Carraro DM
Oncotarget; 2016 Nov; 7(46):75672-75684. PubMed ID: 27708222
[TBL] [Abstract][Full Text] [Related]
15. A human breast cell model of preinvasive to invasive transition.
Rizki A; Weaver VM; Lee SY; Rozenberg GI; Chin K; Myers CA; Bascom JL; Mott JD; Semeiks JR; Grate LR; Mian IS; Borowsky AD; Jensen RA; Idowu MO; Chen F; Chen DJ; Petersen OW; Gray JW; Bissell MJ
Cancer Res; 2008 Mar; 68(5):1378-87. PubMed ID: 18316601
[TBL] [Abstract][Full Text] [Related]
16. Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer.
Zhuang Z; Merino MJ; Chuaqui R; Liotta LA; Emmert-Buck MR
Cancer Res; 1995 Feb; 55(3):467-71. PubMed ID: 7834608
[TBL] [Abstract][Full Text] [Related]
17. The transition from ductal carcinoma in situ to invasive breast cancer: the other side of the coin.
Schnitt SJ
Breast Cancer Res; 2009; 11(1):101. PubMed ID: 19291276
[TBL] [Abstract][Full Text] [Related]
18. Transcriptomic changes in human breast cancer progression as determined by serial analysis of gene expression.
Abba MC; Drake JA; Hawkins KA; Hu Y; Sun H; Notcovich C; Gaddis S; Sahin A; Baggerly K; Aldaz CM
Breast Cancer Res; 2004; 6(5):R499-513. PubMed ID: 15318932
[TBL] [Abstract][Full Text] [Related]
19. [Early and "latent" breast cancer].
Gol'bert ZV; Ostrovtsev LD; Sorkin EE
Vopr Onkol; 1981; 27(10):34-9. PubMed ID: 7303556
[TBL] [Abstract][Full Text] [Related]
20. Double immunolabeling with cytokeratin and smooth-muscle actin in confirming early invasive carcinoma of breast.
Prasad ML; Hyjek E; Giri DD; Ying L; O'Leary JJ; Hoda SA
Am J Surg Pathol; 1999 Feb; 23(2):176-81. PubMed ID: 9989844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
